BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685. [PMID: 21994847 DOI: 10.4061/2011/104685] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Tu T, Budzinska MA, Maczurek AE, Cheng R, Di Bartolomeo A, Warner FJ, McCaughan GW, McLennan SV, Shackel NA. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int J Mol Sci. 2014;15:9422-9458. [PMID: 24871369 DOI: 10.3390/ijms15069422] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
2 Luu HM, van Walsum T, Franklin D, Pham PC, Vu LD, Moelker A, Staring M, VanHoang X, Niessen W, Trung NL. Efficiently compressing 3D medical images for teleinterventions via CNNs and anisotropic diffusion. Med Phys 2021;48:2877-90. [PMID: 33656213 DOI: 10.1002/mp.14814] [Reference Citation Analysis]
3 Somasundaram VH, Pillai R, Malarvizhi G, Ashokan A, Gowd S, Peethambaran R, Palaniswamy S, Unni A, Nair S, Koyakutty M. Biodegradable Radiofrequency Responsive Nanoparticles for Augmented Thermal Ablation Combined with Triggered Drug Release in Liver Tumors. ACS Biomater Sci Eng 2016;2:768-79. [DOI: 10.1021/acsbiomaterials.5b00511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
4 Nagai M, Yamaguchi M, Mori K, Furuta T, Ashino H, Kurosawa H, Kasahara H, Minami M, Fujii H. Magnetic Resonance-Based Visualization of Thermal Ablative Margins Around Hepatic Tumors by Means of Systemic Ferucarbotran Administration Before Radiofrequency Ablation: Animal Study to Reveal the Connection Between Excess Iron Deposition and T2*-Weighted Hypointensity in Ablative Margins. Investigative Radiology 2015;50:376-83. [DOI: 10.1097/rli.0000000000000137] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 2019; 25(21): 2636-2649 [PMID: 31210715 DOI: 10.3748/wjg.v25.i21.2636] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Givehchi S, Wong YH, Yeong CH, Abdullah BJJ. Optimal approach for complete liver tumor ablation using radiofrequency ablation: a simulation study. Minimally Invasive Therapy & Allied Technologies 2018;27:81-9. [DOI: 10.1080/13645706.2017.1330757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC 2nd. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2013;107:544-549. [PMID: 23090720 DOI: 10.1002/jso.23280] [Cited by in Crossref: 206] [Cited by in F6Publishing: 193] [Article Influence: 20.6] [Reference Citation Analysis]
8 Ippolito D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion. Abdom Imaging. 2013;38:502-510. [PMID: 22743839 DOI: 10.1007/s00261-012-9924-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
9 Ratanaprasatporn L, Charpentier KP, Resnick M, Lu S, Dupuy D. Intra-operative microwave ablation of liver malignancies with tumour permittivity feedback control: a prospective ablate and resect study. HPB (Oxford) 2013;15:997-1001. [PMID: 23551845 DOI: 10.1111/hpb.12084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
10 Zhou W, Ding Q, Liu X, Jiang Y, Chen L, Zhang Y, Xia T, Wang S. Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in rabbits. World J Surg Oncol 2012;10:97. [PMID: 22647138 DOI: 10.1186/1477-7819-10-97] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Citone M, Fanelli F, Falcone G, Mondaini F, Cozzi D, Miele V. A closer look to the new frontier of artificial intelligence in the percutaneous treatment of primary lesions of the liver. Med Oncol 2020;37:55. [PMID: 32424627 DOI: 10.1007/s12032-020-01380-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Abdullah BJ, Yeong CH, Goh KL, Yoong BK, Ho GF, Yim CC, Kulkarni A. Robotic-assisted thermal ablation of liver tumours. Eur Radiol 2015;25:246-57. [PMID: 25189152 DOI: 10.1007/s00330-014-3391-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
13 Park HJ, Lee MW, Song KD, Cha DI, Rhim H, Kang TW, Lim S, Lim HK. Comparison of therapeutic efficacy and safety of radiofrequency ablation of hepatocellular carcinomas between internally cooled 15-G and 17-G single electrodes. Br J Radiol 2014;87:20130534. [PMID: 24646182 DOI: 10.1259/bjr.20130534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379:191-197. [PMID: 26213370 DOI: 10.1016/j.canlet.2015.07.018] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
15 Tsuchida S, Fukumoto T, Toyokawa A, Awazu M, Kusunoki N, Kido M, Takahashi M, Tanaka M, Kuramitsu K, Kim SR, Ku Y, Kudo M. Novel non-trocar technique for laparoscopic radiofrequency ablation. Dig Dis 2012;30:588-91. [PMID: 23258099 DOI: 10.1159/000343071] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Byrne TJ, Rakela J. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World J Transplant 2016; 6(2): 306-313 [PMID: 27358775 DOI: 10.5500/wjt.v6.i2.306] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
17 Iida H, Aihara T, Ikuta S, Yamanaka N. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas: RFA or resection for poorly differentiated HCC. Hepatol Res 2014;44:E156-62. [DOI: 10.1111/hepr.12264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
18 Saito T, Chiba T, Ogasawara S, Inoue M, Wakamatsu T, Motoyama T, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Matsubara H, Yokosuka O. Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review. Case Rep Oncol 2015;8:238-45. [PMID: 26120308 DOI: 10.1159/000431310] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Joo I, Choi BI. New paradigm for management of hepatocellular carcinoma by imaging. Liver Cancer. 2012;1:94-109. [PMID: 24159577 DOI: 10.1159/000342404] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
20 Pezeshki PS, Woo J, Akens MK, Davies JE, Gofeld M, Whyne CM, Yee AJ. Evaluation of a bipolar-cooled radiofrequency device for ablation of bone metastases: preclinical assessment in porcine vertebrae. Spine J 2014;14:361-70. [PMID: 24275617 DOI: 10.1016/j.spinee.2013.08.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
21 Högberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, Mölne J, Gjertsson P, Bernhardt P. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy. EJNMMI Res 2014;4:48. [PMID: 26116112 DOI: 10.1186/s13550-014-0048-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
22 Chang XW, Ma XX, Zhu RT, Li J. Imaging evaluation of residual cancer after radiofrequency ablation of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(10): 1539-1544 [DOI: 10.11569/wcjd.v24.i10.1539] [Reference Citation Analysis]
23 Ping X, Tseng Y, Lin Y, Chiu H, Lai F, Liang J, Huang G, Yang P. A multiple measurements case-based reasoning method for predicting recurrent status of liver cancer patients. Computers in Industry 2015;69:12-21. [DOI: 10.1016/j.compind.2015.01.007] [Cited by in Crossref: 30] [Article Influence: 4.3] [Reference Citation Analysis]
24 Liu J, Wu Y, Xu E, Huang Q, Ye H, Tan L, Zheng R, Zeng Q, Li K. Risk factors of intrahepatic biloma and secondary infection after thermal ablation for malignant hepatic tumors. Int J Hyperthermia 2019;36:980-5. [PMID: 31544547 DOI: 10.1080/02656736.2019.1660422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Yun D, Kim S, Song I, Chun K. Comparative analysis of Laparoscopic versus open surgical radiofrequency ablation for malignant liver tumors. Korean J Hepatobiliary Pancreat Surg 2014;18:122-8. [PMID: 26155264 DOI: 10.14701/kjhbps.2014.18.4.122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
26 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wang Y, Luo Q, Li Y, Deng S, Wei S, Li X. Radiofrequency ablation vs hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS One. 2014;9:e84484. [PMID: 24404166 DOI: 10.1371/journal.pone.0084484] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 10.6] [Reference Citation Analysis]
28 Ashoori N, Bamberg F, Paprottka P, Rentsch M, Kolligs FT, Siegert S, Peporte A, Al-Tubaikh JA, D’Anastasi M, Hoffmann RT. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation. Digestion. 2012;86:338-348. [PMID: 23207185 DOI: 10.1159/000342813] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
29 Al-alem I, Pillai K, Akhter J, Chua TC, Morris DL. Heat Sink Phenomenon of Bipolar and Monopolar Radiofrequency Ablation Observed Using Polypropylene Tubes for Vessel Simulation. Surg Innov 2014;21:269-76. [DOI: 10.1177/1553350613505713] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
30 Leveque MK. A Selective Review of Commonly Used Sonography-Guided Hyperthermic Ablative Technologies for Malignant Lesions of the Liver. Journal of Diagnostic Medical Sonography 2012;28:120-5. [DOI: 10.1177/8756479312441504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Wang Y, Luo Q, Li Y, Deng S, Li X, Wei S. A systematic assessment of the quality of systematic reviews/meta-analyses in radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: Quality assessment for small HCC. Journal of Evidence-Based Medicine 2014;7:103-20. [DOI: 10.1111/jebm.12100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
32 Xu C, Zheng Y, Gao W, Xu J, Zuo G, Chen Y, Zhao M, Li J, Song J, Zhang N, Wang Z, Zhao H, Mei Z. Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe 3 O 4 /Calcium Phosphate Cement. ACS Appl Mater Interfaces 2015;7:13866-75. [DOI: 10.1021/acsami.5b02077] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
33 Su XF, Li N, Chen XF, Zhang L, Yan M. Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm. Hepat Mon 2016;16:e34588. [PMID: 27642345 DOI: 10.5812/hepatmon.34588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
34 Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021;18:293-313. [PMID: 33510460 DOI: 10.1038/s41575-020-00395-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
35 Martin RCG. Irreversible Electroporation: a Novel Option for Treatment of Hepatic Metastases. Curr Colorectal Cancer Rep 2013;9:191-7. [DOI: 10.1007/s11888-013-0166-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Scharll Y, Mitteregger A, Laimer G, Schwabl C, Schullian P, Bale R. Comparison of a Robotic and Patient-Mounted Device for CT-Guided Needle Placement: A Phantom Study. JCM 2022;11:3746. [DOI: 10.3390/jcm11133746] [Reference Citation Analysis]
37 Lee S, Han S, Shim JH, Kim SY, Won HJ, Shin YM, Kim PN, An J, Lee D, Kim KM, Lim YS, Chung YH, Lee YS, Lee HC. A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma. J Vasc Interv Radiol 2015;26:1787-94.e1. [PMID: 26542708 DOI: 10.1016/j.jvir.2015.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kuo Y, Chung K, Hung C, Lu S, Wang J. The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences 2014;30:559-65. [DOI: 10.1016/j.kjms.2014.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
39 Wang WD, Zhang LH, Ni JY, Jiang XY, Chen D, Chen YT, Sun HL, Luo JH, Xu LF. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis. Korean J Radiol 2018;19:613-22. [PMID: 29962868 DOI: 10.3348/kjr.2018.19.4.613] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
40 Iida H, Aihara T, Ikuta S, Yamanaka N. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol 2012; 18(41): 5870-5878 [PMID: 23139602 DOI: 10.3748/wjg.v18.i41.5870] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
41 Huang CY, Batzorig U, Cheng WL, Huang MT, Chen W, Wei PL, Chang YJ. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma. Tumour Biol 2016;37:4295-304. [PMID: 26493996 DOI: 10.1007/s13277-015-4254-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
42 Liu C, Li T, He JT, Shao H. TACE combined with microwave ablation therapy vs. TACE alone for treatment of early- and intermediate-stage hepatocellular carcinomas larger than 5 cm: a meta-analysis. Diagn Interv Radiol 2020;26:575-83. [PMID: 32965220 DOI: 10.5152/dir.2020.19615] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Amini A, Gamblin TC. Palliation: treating patients with inoperable biliary tract and primary liver tumors. Surg Oncol Clin N Am. 2014;23:383-397. [PMID: 24560116 DOI: 10.1016/j.soc.2013.10.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Ziegle J, Audigier C, Krug J, Ali G, Kim Y, Boctor EM, Friebe M. RF-ablation pattern shaping employing switching channels of dual bipolar needle electrodes: ex vivo results. Int J CARS 2018;13:905-16. [DOI: 10.1007/s11548-018-1769-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Nakamura M, Hayami S, Ueno M, Kawai M, Miyamoto A, Suzaki N, Hirono S, Okada KI, Miyazawa M, Kitahata Y, Yamaue H. Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma: a case report. Surg Case Rep 2018;4:76. [PMID: 30003446 DOI: 10.1186/s40792-018-0485-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zhou W, Liang M, Pan H, Liu X, Jiang Y, Wang Y, Ling L, Ding Q, Wang S. Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine models. PLoS One 2013;8:e71873. [PMID: 23951262 DOI: 10.1371/journal.pone.0071873] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
47 Ding H, Su M, Zhu C, Wang L, Zheng Q, Wan Y. CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome. Sci Rep 2017;7:44583. [PMID: 28291254 DOI: 10.1038/srep44583] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
48 Miyazaki M, Iguchi T, Takaki H, Yamanaka T, Tamura Y, Tokue H, Sato Y, Ikeda O, Shimizu T, Yamakado K. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Jpn J Radiol 2016;34:647-56. [DOI: 10.1007/s11604-016-0569-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
49 Ni JY, Xu LF, Sun HL, Zhou JX, Chen YT, Luo JH. Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients. J Cancer Res Clin Oncol. 2013;139:2021-2033. [PMID: 24072235 DOI: 10.1007/s00432-013-1530-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
50 Baust JM, Rabin Y, Polascik TJ, Santucci KL, Snyder KK, Van Buskirk RG, Baust JG. Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome. Technol Cancer Res Treat 2018;17:1533033818762207. [PMID: 29566612 DOI: 10.1177/1533033818762207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Zhang R, Ma M, Dong G, Yao RR, Li JH, Zheng QD, Dong YY, Ma H, Gao DM, Cui JF, Ren ZG, Chen RX. Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment. Cancer Sci 2017;108:1778-86. [PMID: 28699238 DOI: 10.1111/cas.13322] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
52 Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 2015; 7(8): 1054-1063 [PMID: 26052394 DOI: 10.4254/wjh.v7.i8.1054] [Cited by in Crossref: 154] [Cited by in F6Publishing: 121] [Article Influence: 22.0] [Reference Citation Analysis]
53 He Q, Kuang AR, Guan YS, Liu YQ. Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma. World J Gastroenterol 2012; 18(46): 6861-6864 [PMID: 23239926 DOI: 10.3748/wjg.v18.i46.6861] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ippolito D, Fior D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. Eur J Radiol. 2014;83:1665-1671. [PMID: 24962900 DOI: 10.1016/j.ejrad.2014.05.040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
55 Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS One 2013;8:e74327. [PMID: 23977399 DOI: 10.1371/journal.pone.0074327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
56 Birsen O, Aliyev S, Aksoy E, Taskin HE, Akyuz M, Karabulut K, Siperstein A, Berber E. A Critical Analysis of Postoperative Morbidity and Mortality After Laparoscopic Radiofrequency Ablation of Liver Tumors. Ann Surg Oncol 2014;21:1834-40. [DOI: 10.1245/s10434-014-3526-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]